Biocept reported $9.61M in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 6324M 584M
Becton, Dickinson and BDX:US $ 2067M 238M
Biocept BIOC:US $ 9.61M 5.66M
General Electric GE:US $ 5040M 829M
Illumina ILMN:US $ 767M 48M
Quest Diagnostics DGX:US $ 842M 126M
Thermo Fisher Scientific TMO:US $ 4730M 734M